We’re building a rich platform of enabling technologies that give our scientists, partners and collaborators access to the best tools to carry out their work. These include both capabilities we house within the Indiana Biosciences Research Institute (IBRI) and those we access through key vendor relationships and strategic partnerships.
Additionally, the IBRI's unique technology footprint is enabling local innovators to translate novel hypotheses into attractive opportunities through innovative discovery and business models.
Back to Scientific Areas.
- Eli Lilly and Company
- Indiana University School of Medicine